Jong-Dai Kim Selected Research

Jong-Dai Kim Research Topics

Disease

15	Ischemia 12/2022 - 04/2011
11	Transient Ischemic Attack 12/2017 - 04/2011
4	Reperfusion Injury 12/2022 - 01/2019
4	Brain Injuries (Brain Injury) 04/2022 - 01/2018
4	Brain Ischemia (Cerebral Ischemia) 01/2019 - 02/2016
3	Cognitive Dysfunction 12/2022 - 08/2016
3	Type 2 Diabetes Mellitus (MODY) 03/2021 - 01/2018
3	Inflammation (Inflammations) 03/2019 - 01/2010
2	Cardiovascular Diseases (Cardiovascular Disease) 03/2021 - 09/2020
1	Hyperparathyroidism 01/2023
1	Hyperphosphatemia 01/2023
1	Chronic Renal Insufficiency 01/2023
1	Secondary Hyperparathyroidism 01/2023
1	Body Weight (Weight, Body) 09/2020
1	Obesity 01/2019
1	Gliosis 12/2017
1	Asphyxia (Suffocation) 12/2017
1	Neurodegenerative Diseases (Neurodegenerative Disease) 02/2017
1	Cerebrovascular Disorders (Cerebrovascular Occlusion) 08/2016
1	Brain Hypoxia-Ischemia (Hypoxia Ischemia, Brain) 09/2013
1	Hypoxia (Hypoxemia) 09/2013
1	Brain Infarction 09/2013

Drug/Important Bio-Agent (IBA)

14	Neuroprotective AgentsIBA 04/2022 - 09/2011
6	AntioxidantsIBA 04/2022 - 01/2014
5	salicylhydroxamic acid (SHAM)IBA 11/2015 - 04/2011
4	Superoxide DismutaseIBA 04/2022 - 02/2013
3	EnzymesIBA 04/2022 - 02/2017
3	tanshinoneIBA 08/2016 - 09/2013
2	Indicators and Reagents (Reagents)IBA 09/2021 - 04/2021
2	Immunoglobulin G (IgG)IBA 09/2021 - 04/2021
2	decursinIBA 04/2021 - 10/2012
2	dapagliflozinIBA 03/2021 - 09/2020
2	fucoidanIBA 01/2019 - 01/2019
2	Scopolamine (Hyoscine)FDA Link 01/2018 - 08/2016
2	Ethanol (Ethyl Alcohol)IBA 12/2017 - 02/2013
2	Fenofibrate (CiL)FDA LinkGeneric 07/2017 - 02/2016
2	Glutathione PeroxidaseIBA 07/2017 - 11/2015
2	DiterpenesIBA 08/2016 - 12/2012
2	Brain-Derived Neurotrophic Factor (BDNF)IBA 01/2014 - 11/2012
2	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 11/2012 - 06/2010
2	Mitogen-Activated Protein Kinase Kinases (MEKs)IBA 06/2010 - 01/2010
1	Cystatin CIBA 01/2023
1	CreatinineIBA 01/2023
1	Cholinergic Agents (Cholinergics)IBA 12/2022
1	Silk FDA Link 12/2022
1	Peptides (Polypeptides)IBA 12/2022
1	astaxanthine (astaxanthin)IBA 04/2022
1	PolyphenolsIBA 09/2021
1	salicinIBA 04/2021
1	Therapeutic UsesIBA 04/2021
1	Sodium-Glucose Transport ProteinsIBA 09/2020
1	Glucose (Dextrose)FDA LinkGeneric 09/2020
1	CholesterolIBA 09/2020
1	LDL CholesterolIBA 09/2020
1	CollagenIBA 03/2019
1	glimepiride (Amarel)FDA LinkGeneric 01/2018
1	Metformin (Glucophage)FDA LinkGeneric 01/2018
1	vanillinIBA 01/2018
1	hydroquinone (Esoterica)FDA Link 12/2017
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 12/2017
1	CatalaseIBA 07/2017
1	peflavitIBA 02/2017
1	FlavonoidsIBA 02/2017
1	QuercetinIBA 02/2017
1	Myelin Basic ProteinIBA 08/2016
1	Interleukin-13IBA 02/2016
1	Complex MixturesIBA 03/2014
1	Nerve Growth Factors (Neurotrophins)IBA 01/2014
1	Superoxide Dismutase-1IBA 01/2014
1	Insulin-Like Growth Factor I (IGF-1)IBA 01/2014
1	fluoro jadeIBA 09/2013
1	triphenyltetrazoliumIBA 09/2013
1	dan-shen root extractIBA 09/2013
1	Eosine Yellowish-(YS) (Eosin)IBA 09/2013
1	Hematoxylin (Haematoxylon)IBA 09/2013
1	SolventsIBA 02/2013
1	8-Hydroxy-2'-DeoxyguanosineIBA 02/2013
1	4-hydroxy-2-nonenal (4-hydroxynonenal)IBA 02/2013
1	Glial Cell Line-Derived Neurotrophic Factor (GDNF)IBA 11/2012
1	Thioctic Acid (Lipoic Acid)IBA 10/2012
1	Proteins (Proteins, Gene)FDA Link 09/2011
1	Leptin ReceptorsIBA 04/2011
1	LeptinIBA 04/2011
1	Phosphatidylinositol 3-Kinase (1 Phosphatidylinositol 3 Kinase)IBA 06/2010
1	Intercellular Adhesion Molecule-1 (Intercellular Adhesion Molecule 1)IBA 01/2010
1	sesaminIBA 01/2010
1	Vascular Cell Adhesion Molecule-1 (Vascular Cell Adhesion Molecule 1)IBA 01/2010
1	p38 Mitogen-Activated Protein KinasesIBA 01/2010

Therapy/Procedure

2	Therapeutics 01/2018 - 12/2017
1	Induced Heart Arrest (Cardioplegia) 12/2017
1	Oral Administration 09/2011